“Swimming in resistance”: Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa-Reference-Cited by-同舟云学术

“Swimming in resistance”: Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa

Published:2012-11 Issue:9 Volume:40 Page:830-835
ISSN:0196-6553
Container-title:American Journal of Infection Control
language:en
Short-container-title:American Journal of Infection Control

Author:

Marchaim Dror,Perez Federico,Lee Jiha,Bheemreddy Suchitha,Hujer Andrea M.,Rudin Susan,Hayakawa Kayoko,Lephart Paul R.,Blunden Christopher,Shango Maryann,Campbell Michelle L.,Varkey Jastin,Manickam Palaniappan,Patel Diixa,Pogue Jason M.,Chopra Teena,Martin Emily T.,Dhar Sorabh,Bonomo Robert A.,Kaye Keith S.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Health Policy,Epidemiology

Reference26 articles.

1. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria;Nordmann;Lancet Infect Dis,2009

2. Carbapenem-resistant Enterobacteriaceae: a potential threat;Schwaber;JAMA,2008

3. Impact of multidrug-resistant Acinetobacter baumannii on clinical outcomes;Abbo;Eur J Clin Microbiol Infect Dis,2007

4. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America;Boucher;Clin Infect Dis,2009

5. Has the era of untreatable infections arrived?;Livermore;J Antimicrob Chemother,2009

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a risk prediction model for subsequent infection after colonization with carbapenem-resistant Enterobacterales: a retrospective cohort study;Antimicrobial Resistance & Infection Control;2024-04-24

2. Risk Factors and Clinical Characteristics of Pandrug-Resistant Pseudomonas aeruginosa;Cureus;2024-04-12

3. Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis;Frontiers in Cellular and Infection Microbiology;2023-10-16

4. In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales;Journal of Antimicrobial Chemotherapy;2023-10-16

5. Spatiotemporal Evolution of Coinfection Dynamics: A Reaction–Diffusion Model;Journal of Dynamics and Differential Equations;2023-09-15